The elective medical industry is cashing in on plastic pollution fears, but the evidence of harm from microplastics is still ...

Nitisinone, a drug that is already used to treat two genetic diseases, could be repurposed to control the spread of malaria, ...

In a nutshell A rare disease drug may help fight malaria. Nitisinone, a medication approved for rare genetic conditions, killed malaria-carrying mosquitoes after they fed on treated human blood — ...

The researchers gave female Anopheles gambiae mosquitoes, which transmit malaria, blood samples obtained from three individuals who regularly take nitisinone. The mosquitoes died within 12 hours.

Samples from both groups showed ... to the physiological blood loss associated with blood donation. Finally, the team transplanted the human stem cells carrying the two types of mutations into ...

Archer Materials (ASX: AXE) has signed an agreement with Canadian medical device company Hylid Diagnostics to develop a ...

Samples from both groups showed ... to the physiological blood loss associated with blood donation. Finally, the team transplanted the human stem cells carrying the two types of mutations into ...

Scientists at the Francis Crick Institute in London studied blood samples from 217 men who had ... lab experiments using genetically modified human blood stem cells to understand why this mutation ...

Though “human involvement can certainly be reassuring ... Normally, with traditional blood draws, the hemolysis rate of blood samples can be as high as 3% to 4%, according to published research.